Skip to main content
icon for Measles cases in U.S. by May 31?

Measles cases in U.S. by May 31?

icon for Measles cases in U.S. by May 31?

Measles cases in U.S. by May 31?

May 31

Dec 31

May 31

Dec 31

$68,236 Обс.

May 31, 2026
Polymarket

$68,236 Обс.

Polymarket

1900

$29,844 Обс.

99%

1925

$5,375 Обс.

97%

1950

$11,650 Обс.

67%

2000

$12,987 Обс.

7%

2200

$2,644 Обс.

2%

2400

$955 Обс.

1%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC surveillance data show the U.S. measles case total already exceeding 1,800 confirmed infections by mid-May 2026, driven primarily by large, ongoing outbreaks in multiple states among unvaccinated children and adolescents. With 92 percent of cases linked to individuals who are unvaccinated or whose status is unknown, transmission remains efficient in communities with coverage gaps below the 95 percent herd-immunity threshold. Official counts continue rising at a pace that places the cumulative total well above typical seasonal benchmarks, with weekly CDC updates and summer travel season expected to add further cases before the May 31 resolution window closes. Traders are therefore pricing near-certainty on higher thresholds, reflecting both the current trajectory and the limited time remaining for any meaningful slowdown in reported incidence.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$68,236
Дата завершення
May 31, 2026
Ринок відкрито
Apr 28, 2026, 6:09 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Recent CDC surveillance data show the U.S. measles case total already exceeding 1,800 confirmed infections by mid-May 2026, driven primarily by large, ongoing outbreaks in multiple states among unvaccinated children and adolescents. With 92 percent of cases linked to individuals who are unvaccinated or whose status is unknown, transmission remains efficient in communities with coverage gaps below the 95 percent herd-immunity threshold. Official counts continue rising at a pace that places the cumulative total well above typical seasonal benchmarks, with weekly CDC updates and summer travel season expected to add further cases before the May 31 resolution window closes. Traders are therefore pricing near-certainty on higher thresholds, reflecting both the current trajectory and the limited time remaining for any meaningful slowdown in reported incidence.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$68,236
Дата завершення
May 31, 2026
Ринок відкрито
Apr 28, 2026, 6:09 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Обережно з зовнішніми посиланнями.

Часті запитання

«Measles cases in U.S. by May 31?» — це ринок прогнозів на Polymarket з 7 можливими результатами, де трейдери купують і продають акції залежно від того, що, на їхню думку, станеться. Поточний лідер — «1800» з 100%, далі «1900» з 99%. Ціни відображають краудсорсингові ймовірності в реальному часі. Акції правильного результату погашаються по $1 кожна при вирішенні ринку.

Станом на сьогодні, «Measles cases in U.S. by May 31?» згенерував $68.2K загального обсягу торгів з моменту запуску ринку Apr 27, 2026. Цей рівень торгової активності відображає сильну залученість спільноти Polymarket та забезпечує, що поточні шанси базуються на глибокому пулі учасників ринку. Ви можете відстежувати рухи цін наживо та торгувати будь-яким результатом прямо на цій сторінці.

Щоб торгувати на «Measles cases in U.S. by May 31?», перегляньте 7 доступних результатів на цій сторінці. Кожен результат відображає поточну ціну — ймовірність ринку. Оберіть результат, оберіть «Так» чи «Ні», введіть суму та натисніть «Торгувати». Якщо ваш вибір правильний при вирішенні, акції «Так» виплачують $1. Якщо ні — $0. Ви також можете продати акції в будь-який час до вирішення.

Поточний фаворит для «Measles cases in U.S. by May 31?» — «1800» з 100%. Наступний — «1900» з 99%. Ці шанси оновлюються в реальному часі, коли трейдери купують і продають акції. Слідкуйте за змінами шансів з появою нової інформації.

Правила вирішення для «Measles cases in U.S. by May 31?» точно визначають, що має статися для оголошення переможця — включаючи офіційні джерела даних. Ви можете переглянути повні критерії вирішення в розділі «Правила» на цій сторінці. Рекомендуємо уважно прочитати правила перед торгівлею.